ArticleBMC cancer2020

Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma.

Xia Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.